Onivyde liposomal pégylé 4.3 mg/ml
Onivyde liposomal pégylé 4.3 mg/ml is a medicine authorised by Swissmedic under authorisation number 65994. The authorisation holder is Servier (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 July 2017 and the authorisation is valid without a time limit. ATC code L01CE02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 65994 |
|---|---|
| Name | Onivyde liposomal pégylé 4.3 mg/ml |
| Full name | Onivyde liposomal pégylé 4.3 mg/ml, dispersion à diluer pour perfusion |
| Authorisation holder | Servier (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01CE02 |
| First authorisation | 25 July 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Onivyde liposomal pégylé 4.3 mg/ml, dispersion à diluer pour perfusion | A | 25 July 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 1 | Durchstechflasche(n) | L01CE02 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Onivyde liposomal pégylé 4.3 mg/ml authorised in Switzerland?
Yes. Onivyde liposomal pégylé 4.3 mg/ml is authorised by Swissmedic under authorisation number 65994, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Onivyde liposomal pégylé 4.3 mg/ml have?
Onivyde liposomal pégylé 4.3 mg/ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Onivyde liposomal pégylé 4.3 mg/ml?
The authorisation holder is Servier (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.